Skip to content
ProPublica Donate
ProPublica Donate

McKinsey’s Rules

When Consultants Work For Governments

How McKinsey & Co., best known for advising Fortune 500 corporations, played by its own rules as it expanded into assignments for government clients.

Impact of Our Reporting
Caret

McKinsey’s Rules

Congress Passes Bill to Rein in Conflicts of Interest for Consultants Such as McKinsey

President Joe Biden is expected to sign the legislation, whose Senate sponsors cited ProPublica’s reporting on McKinsey’s conflicts in working for both the FDA and opioid makers like Purdue Pharma.

by Ian MacDougall,

McKinsey’s Rules

Citing ProPublica’s Reporting on McKinsey, Senators Propose Bill Addressing Contractors’ Conflicts of Interest

McKinsey consulted for the FDA without informing the agency of its work for opioid makers. Now lawmakers have introduced a bill to ensure federal contractors disclose conflicts of interest arising from private-sector work.

by Ian MacDougall,

7 stories published since 2019

McKinsey Never Told the FDA It Was Working for Opioid Makers While Also Working for the Agency

by Ian MacDougall for ProPublica,

How McKinsey Is Making $100 Million (and Counting) Advising on the Government’s Bumbling Coronavirus Response

by Ian MacDougall for ProPublica,

McKinsey Called Our Story About Its ICE Contract False. It’s Not.

by Ian MacDougall,

How McKinsey Makes Its Own Rules

by Ian MacDougall,

New York City Paid McKinsey Millions to Stem Jail Violence. Instead, Violence Soared.

by Ian MacDougall,

How McKinsey Helped the Trump Administration Detain and Deport Immigrants

by Ian MacDougall,

The Country That Exiled McKinsey

by Ian MacDougall, ProPublica, and Anand Tumurtogoo for ProPublica,

What We’re Watching

During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.

Learn more about our reporting team. We will continue to share our areas of interest as the news develops.

Photo of Sharon Lerner
Sharon Lerner

I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.

Photo of Andy Kroll
Andy Kroll

I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.

Photo of Melissa Sanchez
Melissa Sanchez

I report on immigration and labor, and I am based in Chicago.

Photo of Jesse Coburn
Jesse Coburn

I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.

If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our federal worker source network to stay in touch.

Most Read

    ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs

    The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign factories. The request was part of ProPublica’s ongoing investigation into the safety of America’s generic drug supply.

    by Katherine Dailey and Jessie Nguyen, Medill Investigative Lab,

    Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs

    A ProPublica investigation found that for more than a decade, the FDA gave substandard factories banned from the United States a special pass to keep sending drugs to an unsuspecting public.

    by Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang,

    Federal Judge Deems Trump Administration’s Termination of NIH Grants Illegal

    In a ruling issued Monday, the judge called the government’s directives “arbitrary and capricious” and ordered funding for some of the NIH grants, including many profiled by ProPublica in recent months, to be restored.

    by Annie Waldman,

    “The Intern in Charge”: Meet the 22-Year-Old Trump’s Team Picked to Lead Terrorism Prevention

    One year out of college and with no apparent national security expertise, Thomas Fugate is the Department of Homeland Security official tasked with overseeing the government’s main hub for combating violent extremism.

    by Hannah Allam,

    We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market

    Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into the U.S. over the past dozen years even though they were made at factories banned from shipping their products here.

    by Brandon Roberts, Debbie Cenziper, Megan Rose and Irena Hwang,